{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:24:16Z","timestamp":1770823456364,"version":"3.50.1"},"reference-count":144,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","immunology.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.iac.2015.05.001","type":"journal-article","created":{"date-parts":[[2015,6,17]],"date-time":"2015-06-17T04:54:19Z","timestamp":1434516859000},"page":"453-476","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Eosinophilia in Rheumatologic\/Vascular Disorders"],"prefix":"10.1016","volume":"35","author":[{"given":"Hiromichi","family":"Tamaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soumya","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol A.","family":"Langford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.iac.2015.05.001_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.iac.2015.05.001_bib2","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1055\/s-0031-1279824","article-title":"Epidemiology and etiology of Wegener granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and Goodpasture syndrome: vasculitides with frequent lung involvement","volume":"32","author":"Gibelin","year":"2011","journal-title":"Semin Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.iac.2015.05.001_bib3","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3109\/14397595.2013.857582","article-title":"A\u00a0nationwide survey on the epidemiology and clinical features of eosinophilic granulomatosis with polyangiitis (Churg-Strauss) in Japan","volume":"24","author":"Sada","year":"2014","journal-title":"Mod Rheumatol"},{"issue":"3","key":"10.1016\/j.iac.2015.05.001_bib4","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1081-1206(10)62015-7","article-title":"Prevalence of serious eosinophilia and incidence of Churg-Strauss syndrome in a cohort of asthma patients","volume":"88","author":"Loughlin","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.iac.2015.05.001_bib5","first-page":"1076","article-title":"Incidence of Churg-Strauss syndrome in asthma drug users: a population-based perspective","volume":"32","author":"Harrold","year":"2005","journal-title":"J\u00a0Rheumatol"},{"issue":"9","key":"10.1016\/j.iac.2015.05.001_bib6","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1002\/art.22834","article-title":"HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome","volume":"56","author":"Vaglio","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.iac.2015.05.001_bib7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/art.23209","article-title":"Associations of Churg-Strauss syndrome with the HLA-DRB1 locus, and relationship to the genetics of antineutrophil cytoplasmic antibody-associated vasculitides: comment on the article by Vaglio et\u00a0al","volume":"58","author":"Wieczorek","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.iac.2015.05.001_bib8","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1002\/art.23496","article-title":"Functionally relevant variations of the interleukin-10 gene associated with antineutrophil cytoplasmic antibody-negative Churg-Strauss syndrome, but not with Wegener's granulomatosis","volume":"58","author":"Wieczorek","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.iac.2015.05.001_bib9","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1136\/thx.2007.087825","article-title":"The leucotriene receptor antagonist montelukast and the risk of Churg-Strauss syndrome: a case-crossover study","volume":"63","author":"Hauser","year":"2008","journal-title":"Thorax"},{"issue":"10","key":"10.1016\/j.iac.2015.05.001_bib10","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1136\/thx.2007.093955","article-title":"Churg-Strauss syndrome and leukotriene antagonist use: a respiratory perspective","volume":"63","author":"Nathani","year":"2008","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.iac.2015.05.001_bib11","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/thx.2009.120972","article-title":"Association between leukotriene receptor antagonist therapy and Churg-Strauss syndrome: an analysis of the FDA AERS database","volume":"65","author":"Bibby","year":"2010","journal-title":"Thorax"},{"issue":"6442","key":"10.1016\/j.iac.2015.05.001_bib12","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1136\/bmj.289.6442.400","article-title":"Deposition of eosinophil cationic protein in granulomas in allergic granulomatosis and vasculitis: the Churg-Strauss syndrome","volume":"289","author":"Tai","year":"1984","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"6","key":"10.1016\/j.iac.2015.05.001_bib13","first-page":"784","article-title":"Usefulness of serum eosinophil cationic protein (ECP) in predicting relapse of Churg and Strauss vasculitis","volume":"18","author":"Hurst","year":"2000","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.iac.2015.05.001_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2500\/108854199778681486","article-title":"Eosinophil active cytokines and surface analysis of eosinophils in Churg-Strauss syndrome","volume":"20","author":"Tsukadaira","year":"1999","journal-title":"Allergy Asthma Proc"},{"issue":"8","key":"10.1016\/j.iac.2015.05.001_bib15","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1034\/j.1398-9995.2000.00720.x","article-title":"Interleukins in Churg-Strauss syndrome","volume":"55","author":"Kurosawa","year":"2000","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.iac.2015.05.001_bib16","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/1529-0131(200102)44:2<469::AID-ANR66>3.0.CO;2-0","article-title":"Elevated interleukin-4 and interleukin-13 production by T cell lines from patients with Churg-Strauss syndrome","volume":"44","author":"Kiene","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"1 Suppl 64","key":"10.1016\/j.iac.2015.05.001_bib17","first-page":"S23","article-title":"Both Th2 and Th17 responses are involved in the pathogenesis of Churg-Strauss syndrome","volume":"29","author":"Jakiela","year":"2011","journal-title":"Clin Exp Rheumatol"},{"issue":"Suppl 1","key":"10.1016\/j.iac.2015.05.001_bib18","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000327265","article-title":"The proportion of regulatory T cells in the peripheral blood reflects the relapse or remission status of patients with Churg-Strauss syndrome","volume":"155","author":"Saito","year":"2011","journal-title":"Int Arch Allergy Immunol"},{"issue":"2","key":"10.1016\/j.iac.2015.05.001_bib19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00005792-198403000-00001","article-title":"Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome","volume":"63","author":"Lanham","year":"1984","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.iac.2015.05.001_bib20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00005792-199901000-00003","article-title":"Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients","volume":"78","author":"Guillevin","year":"1999","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.iac.2015.05.001_bib21","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0002-9343(03)00359-0","article-title":"Churg-Strauss syndrome: clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists","volume":"115","author":"Keogh","year":"2003","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.iac.2015.05.001_bib22","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/art.37721","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group Cohort","volume":"65","author":"Comarmond","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.iac.2015.05.001_bib23","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/MD.0b013e3181af35a5","article-title":"Cardiac involvement in Churg-Strauss syndrome: impact of endomyocarditis","volume":"88","author":"Neumann","year":"2009","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.iac.2015.05.001_bib24","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1053\/j.ajkd.2006.01.026","article-title":"Renal involvement in Churg-Strauss syndrome","volume":"47","author":"Sinico","year":"2006","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1016\/j.iac.2015.05.001_bib25","doi-asserted-by":"crossref","first-page":"632","DOI":"10.7326\/0003-4819-143-9-200511010-00006","article-title":"Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome","volume":"143","author":"Sable-Fourtassou","year":"2005","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.iac.2015.05.001_bib26","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jaci.2012.02.019","article-title":"Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes","volume":"130","author":"Valent","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2015.05.001_bib27","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.jaci.2009.09.022","article-title":"Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy","volume":"124","author":"Ogbogu","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2015.05.001_bib28","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/art.23198","article-title":"Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patients","volume":"58","author":"Ribi","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.iac.2015.05.001_bib29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/MD.0b013e318205a4c6","article-title":"The five-factor score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort","volume":"90","author":"Guillevin","year":"2011","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.iac.2015.05.001_bib30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00005792-199601000-00003","article-title":"Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients","volume":"75","author":"Guillevin","year":"1996","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.iac.2015.05.001_bib31","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/1529-0131(200103)44:3<666::AID-ANR116>3.0.CO;2-A","article-title":"Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients","volume":"44","author":"Gayraud","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.iac.2015.05.001_bib32","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/rheumatology\/36.12.1290","article-title":"Treatment of good-prognosis polyarteritis nodosa and Churg-Strauss syndrome: comparison of steroids and oral or pulse cyclophosphamide in 25 patients. French Cooperative Study Group for vasculitides","volume":"36","author":"Gayraud","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.iac.2015.05.001_bib33","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaut.2013.03.003","article-title":"Long-term outcomes of 118 patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) enrolled in two prospective trials","volume":"43","author":"Samson","year":"2013","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.iac.2015.05.001_bib34","article-title":"Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)","author":"Mohammad","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.iac.2015.05.001_bib35","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.jaci.2010.03.028","article-title":"Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome","volume":"125","author":"Kim","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2015.05.001_bib36","doi-asserted-by":"crossref","first-page":"341","DOI":"10.7326\/0003-4819-155-5-201109060-00026","article-title":"Targeting interleukin-5 in refractory and relapsing Churg-Strauss syndrome","volume":"155","author":"Moosig","year":"2011","journal-title":"Ann Intern Med"},{"issue":"5054","key":"10.1016\/j.iac.2015.05.001_bib37","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1136\/bmj.2.5054.1148","article-title":"The natural history of polyarteritis","volume":"2","author":"ROSE","year":"1957","journal-title":"Br Med J"},{"issue":"12","key":"10.1016\/j.iac.2015.05.001_bib38","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1111\/j.1572-0241.2003.08758.x","article-title":"Autoimmune pancreatitis is a systemic autoimmune disease","volume":"98","author":"Kamisawa","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.iac.2015.05.001_bib39","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.autrev.2014.08.013","article-title":"The clinical spectrum of IgG4-related disease","volume":"13","author":"Brito-Zeron","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"9","key":"10.1016\/j.iac.2015.05.001_bib40","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","article-title":"Consensus statement on the pathology of IgG4-related disease","volume":"25","author":"Deshpande","year":"2012","journal-title":"Mod Pathol"},{"issue":"10","key":"10.1016\/j.iac.2015.05.001_bib41","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1002\/art.34593","article-title":"Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations","volume":"64","author":"Stone","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"9976","key":"10.1016\/j.iac.2015.05.001_bib42","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0140-6736(14)60720-0","article-title":"IgG4-related disease","volume":"385","author":"Kamisawa","year":"2015","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.iac.2015.05.001_bib43","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/MPA.0b013e3182480c99","article-title":"Nationwide epidemiological survey of autoimmune pancreatitis in Japan","volume":"41","author":"Kanno","year":"2012","journal-title":"Pancreas"},{"issue":"9","key":"10.1016\/j.iac.2015.05.001_bib44","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1136\/gut.2006.095059","article-title":"Genetic association of Fc receptor-like 3 polymorphisms with autoimmune pancreatitis in Japanese patients","volume":"55","author":"Umemura","year":"2006","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.iac.2015.05.001_bib45","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00251-006-0178-2","article-title":"Two critical genes (HLA-DRB1 and ABCF1) in the HLA region are associated with the susceptibility to autoimmune pancreatitis","volume":"59","author":"Ota","year":"2007","journal-title":"Immunogenetics"},{"issue":"3","key":"10.1016\/j.iac.2015.05.001_bib46","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1572-0241.2007.01750.x","article-title":"Association of autoimmune pancreatitis with cytotoxic T-lymphocyte antigen 4 gene polymorphisms in Japanese patients","volume":"103","author":"Umemura","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.iac.2015.05.001_bib47","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1155\/2011\/264747","article-title":"Polymorphism in the KCNA3 gene is associated with susceptibility to autoimmune pancreatitis in the Japanese population","volume":"31","author":"Ota","year":"2011","journal-title":"Dis Markers"},{"issue":"1","key":"10.1016\/j.iac.2015.05.001_bib48","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/art.33320","article-title":"Th2 and regulatory immune reactions contribute to IgG4 production and the initiation of Mikulicz disease","volume":"64","author":"Tanaka","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.iac.2015.05.001_bib49","doi-asserted-by":"crossref","first-page":"G723","DOI":"10.1152\/ajpgi.00414.2010","article-title":"Fibrosis is regulated by Th2 and Th17 responses and by dynamic interactions between fibroblasts and macrophages","volume":"300","author":"Barron","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"10","key":"10.1016\/j.iac.2015.05.001_bib50","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1002\/lary.23429","article-title":"Roles of IL-17, Th1, and Tc1 cells in patients with IgG4-related sclerosing sialadenitis","volume":"122","author":"Ohta","year":"2012","journal-title":"Laryngoscope"},{"issue":"1\u20132","key":"10.1016\/j.iac.2015.05.001_bib51","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cca.2009.06.036","article-title":"Serum IgG4 concentrations and IgG4-related sclerosing disease","volume":"408","author":"Tabata","year":"2009","journal-title":"Clin Chim Acta"},{"issue":"8","key":"10.1016\/j.iac.2015.05.001_bib52","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1111\/j.1572-0241.2007.01264.x","article-title":"Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer","volume":"102","author":"Ghazale","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.iac.2015.05.001_bib53","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/annrheumdis-2013-204907","article-title":"The diagnostic utility of serum IgG4 concentrations in IgG4-related disease","volume":"74","author":"Carruthers","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.iac.2015.05.001_bib54","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/MPA.0b013e3182142fd2","article-title":"International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology","volume":"40","author":"Shimosegawa","year":"2011","journal-title":"Pancreas"},{"issue":"2","key":"10.1016\/j.iac.2015.05.001_bib55","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.rdc.2013.02.011","article-title":"Erdheim-Chester disease","volume":"39","author":"Haroche","year":"2013","journal-title":"Rheum Dis Clin North Am"},{"issue":"11","key":"10.1016\/j.iac.2015.05.001_bib56","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1136\/gutjnl-2012-302886","article-title":"Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience","volume":"62","author":"Hart","year":"2013","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.iac.2015.05.001_bib57","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1136\/gutjnl-2012-303617","article-title":"Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis","volume":"62","author":"Hart","year":"2013","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.iac.2015.05.001_bib58","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/art.27435","article-title":"Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease","volume":"62","author":"Khosroshahi","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.iac.2015.05.001_bib59","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/MD.0b013e3182431ef6","article-title":"Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients","volume":"91","author":"Khosroshahi","year":"2012","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.iac.2015.05.001_bib60","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/MPA.0b013e31819d73ca","article-title":"Possible association between IgG4-associated systemic disease with or without autoimmune pancreatitis and non-Hodgkin lymphoma","volume":"38","author":"Takahashi","year":"2009","journal-title":"Pancreas"},{"issue":"4","key":"10.1016\/j.iac.2015.05.001_bib61","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/ajg.2012.465","article-title":"Risk of cancer in patients with autoimmune pancreatitis","volume":"108","author":"Shiokawa","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.iac.2015.05.001_bib62","first-page":"70","article-title":"Diffuse fasciitis with eosinophilia: a new syndrome?","volume":"88","author":"Shulman","year":"1975","journal-title":"Trans Assoc Am Physicians"},{"issue":"4","key":"10.1016\/j.iac.2015.05.001_bib63","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0049-0172(88)90008-X","article-title":"Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases","volume":"17","author":"Lakhanpal","year":"1988","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.iac.2015.05.001_bib64","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2310\/7750.2013.13026","article-title":"Eosinophilic fasciitis occurring under treatment with natalizumab for multiple sclerosis","volume":"18","author":"Bujold","year":"2014","journal-title":"J\u00a0Cutan Med Surg"},{"issue":"9","key":"10.1016\/j.iac.2015.05.001_bib65","first-page":"1144","article-title":"Eosinophilic fasciitis-like disorder developing in the setting of multiple sclerosis therapy","volume":"13","author":"Sheu","year":"2014","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"11","key":"10.1016\/j.iac.2015.05.001_bib66","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1001\/archinte.161.11.1456","article-title":"Eosinophilic fasciitis and simvastatin","volume":"161","author":"Choquet-Kastylevsky","year":"2001","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.iac.2015.05.001_bib67","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2230.2005.01975.x","article-title":"Eosinophilic fasciitis secondary to treatment with atorvastatin","volume":"31","author":"DeGiovanni","year":"2006","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"10.1016\/j.iac.2015.05.001_bib68","first-page":"383","article-title":"Possible association between eosinophilic fasciitis and subcutaneous heparin use","volume":"25","author":"Cantini","year":"1998","journal-title":"J\u00a0Rheumatol"},{"issue":"6","key":"10.1016\/j.iac.2015.05.001_bib69","first-page":"1242","article-title":"Scleroderma and eosinophilic fasciitis in patients taking fosinopril","volume":"24","author":"Biasi","year":"1997","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.iac.2015.05.001_bib70","first-page":"733","article-title":"The eosinophilic fasciitis syndrome after phenytoin (dilantin) therapy","volume":"7","author":"Buchanan","year":"1980","journal-title":"J\u00a0Rheumatol"},{"issue":"4","key":"10.1016\/j.iac.2015.05.001_bib71","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1046\/j.1365-2133.2000.03446.x","article-title":"Eosinophilic fasciitis following exposure to trichloroethylene: successful treatment with cyclosporin","volume":"142","author":"Hayashi","year":"2000","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.iac.2015.05.001_bib72","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1128\/JCM.05568-11","article-title":"Eosinophilic fasciitis associated with mycoplasma arginini infection","volume":"50","author":"Sillo","year":"2012","journal-title":"J\u00a0Clin Microbiol"},{"issue":"5","key":"10.1016\/j.iac.2015.05.001_bib73","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00000372-199610000-00004","article-title":"Borrelial fasciitis: diffuse fasciitis and peripheral eosinophilia associated with Borrelia infection","volume":"18","author":"Granter","year":"1996","journal-title":"Am J Dermatopathol"},{"issue":"2","key":"10.1016\/j.iac.2015.05.001_bib74","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000246339","article-title":"Polymerase chain reaction of Borrelia burgdorferi flagellin gene in Shulman syndrome","volume":"192","author":"Hashimoto","year":"1996","journal-title":"Dermatology"},{"issue":"1","key":"10.1016\/j.iac.2015.05.001_bib75","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-4632.2007.03544.x","article-title":"Eosinophilic fasciitis: demographics, disease pattern and response to treatment: report of 12 cases and review of the literature","volume":"47","author":"Bischoff","year":"2008","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.iac.2015.05.001_bib76","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/ajh.2830240112","article-title":"Bone marrow transplantation in a patient with myelodysplasia associated with diffuse eosinophilic fasciitis","volume":"24","author":"Tallman","year":"1987","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.iac.2015.05.001_bib77","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2133.1997.tb14929.x","article-title":"Eosinophilic fasciitis with myelodysplasia responsive to treatment with cyclosporin","volume":"136","author":"Fleming","year":"1997","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.iac.2015.05.001_bib78","first-page":"316","article-title":"Patients with eosinophilic fasciitis should have a bone marrow examination to identify myelodysplasia","volume":"137","author":"Brito-Babapulle","year":"1997","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.iac.2015.05.001_bib79","first-page":"1185","article-title":"Eosinophilic fasciitis associated with autoimmune thyroid disease and myelodysplasia treated with pulsed methylprednisolone and antihistamines","volume":"140","author":"Farrell","year":"1999","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.iac.2015.05.001_bib80","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3346\/jkms.2000.15.3.346","article-title":"Eosinophilic fasciitis preceding relapse of peripheral T-cell lymphoma","volume":"15","author":"Kim","year":"2000","journal-title":"J\u00a0Korean Med Sci"},{"issue":"6","key":"10.1016\/j.iac.2015.05.001_bib81","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1080\/03009740410005061","article-title":"Eosinophilic fasciitis, myositis and arthritis as early manifestations of peripheral T-cell lymphoma","volume":"32","author":"Eklund","year":"2003","journal-title":"Scand J Rheumatol"},{"issue":"6","key":"10.1016\/j.iac.2015.05.001_bib82","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/archderm.1991.01680050106013","article-title":"Concurrent eosinophilic fasciitis and cutaneous T-cell lymphoma. Eosinophilic fasciitis as a paraneoplastic syndrome of T-cell malignant neoplasms?","volume":"127","author":"Chan","year":"1991","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.iac.2015.05.001_bib83","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/DAD.0b013e3182892230","article-title":"Eosinophilic fasciitis as a manifestation of a cutaneous T-cell lymphoma not otherwise specified","volume":"35","author":"Castellanos-Gonzalez","year":"2013","journal-title":"Am J Dermatopathol"},{"issue":"2","key":"10.1016\/j.iac.2015.05.001_bib84","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000093847","article-title":"Eosinophilic fasciitis 30 years after\u2014what do we really know? Report of 11 patients and review of the literature","volume":"213","author":"Antic","year":"2006","journal-title":"Dermatology"},{"issue":"12","key":"10.1016\/j.iac.2015.05.001_bib85","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1136\/ard.61.12.1111","article-title":"Eosinophilic fasciitis with multiple myeloma: a new haematological association","volume":"61","author":"Khanna","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.iac.2015.05.001_bib86","first-page":"473","article-title":"Eosinophilic fasciitis complicated by Hodgkin's disease","volume":"9","author":"Michaels","year":"1982","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.iac.2015.05.001_bib87","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jbspin.2012.07.008","article-title":"Eosinophilic fasciitis with paroxysmal nocturnal hemoglobinuria","volume":"80","author":"de Boysson","year":"2013","journal-title":"Joint Bone Spine"},{"issue":"2","key":"10.1016\/j.iac.2015.05.001_bib88","first-page":"493","article-title":"Eosinophilic fasciitis. A pathologic study of twenty cases","volume":"96","author":"Barnes","year":"1979","journal-title":"Am J Pathol"},{"issue":"8","key":"10.1016\/j.iac.2015.05.001_bib89","first-page":"1811","article-title":"In situ immunophenotype of the inflammatory infiltrate in eosinophilic fasciitis","volume":"30","author":"Toquet","year":"2003","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.iac.2015.05.001_bib90","first-page":"75","article-title":"Analysis of leukemia inhibitory factor, type 1 and type 2 cytokine production in patients with eosinophilic fasciitis","volume":"28","author":"Viallard","year":"2001","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.iac.2015.05.001_bib91","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1365-2133.2004.06062.x","article-title":"Serum levels of tissue inhibitor of metalloproteinase-1 and 2 in patients with eosinophilic fasciitis","volume":"151","author":"Jinnin","year":"2004","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.iac.2015.05.001_bib92","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.berh.2012.08.001","article-title":"Eosinophilic fasciitis (Shulman disease)","volume":"26","author":"Lebeaux","year":"2012","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"4\u20135","key":"10.1016\/j.iac.2015.05.001_bib93","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.autrev.2014.01.019","article-title":"Diagnosis and classification of eosinophilic fasciitis","volume":"13","author":"Pinal-Fernandez","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.iac.2015.05.001_bib94","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/0002-9343(90)90524-H","article-title":"Capillary microscopy during eosinophilic fasciitis in 15 patients: distinction from systemic scleroderma","volume":"88","author":"Herson","year":"1990","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.iac.2015.05.001_bib95","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11926-011-0220-8","article-title":"Scleroderma mimics","volume":"14","author":"Nashel","year":"2012","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.iac.2015.05.001_bib96","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev.nu.12.070192.001315","article-title":"The eosinophilia-myalgia syndrome and tryptophan","volume":"12","author":"Belongia","year":"1992","journal-title":"Annu Rev Nutr"},{"issue":"6","key":"10.1016\/j.iac.2015.05.001_bib97","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/00002281-199511000-00016","article-title":"Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia","volume":"7","author":"Kaufman","year":"1995","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"10.1016\/j.iac.2015.05.001_bib98","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0049-0172(86)90017-X","article-title":"Toxic oil syndrome: a syndrome with features overlapping those of various forms of scleroderma","volume":"15","author":"Alonso-Ruiz","year":"1986","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.iac.2015.05.001_bib99","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/rheumatology\/ker366","article-title":"Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients","volume":"51","author":"Lebeaux","year":"2012","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.iac.2015.05.001_bib100","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/rheumatology\/ken142","article-title":"Infliximab effective in steroid-dependent juvenile eosinophilic fasciitis","volume":"47","author":"Tzaribachev","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.iac.2015.05.001_bib101","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/rheumatology\/keq062","article-title":"Infliximab may be effective in the treatment of steroid-resistant eosinophilic fasciitis: report of three cases","volume":"49","author":"Khanna","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.iac.2015.05.001_bib102","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.anai.2011.01.021","article-title":"Eosinophilic fasciitis mimicking angioedema and treatment response to infliximab in a pediatric patient","volume":"106","author":"Poliak","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"8","key":"10.1016\/j.iac.2015.05.001_bib103","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5070\/D36148K6D0","article-title":"Eosinophilic fasciitis\/generalized morphea overlap","volume":"15","author":"Heidary","year":"2009","journal-title":"Dermatol Online J"},{"issue":"1","key":"10.1016\/j.iac.2015.05.001_bib104","first-page":"65","article-title":"Rituximab in refractory autoimmune diseases: Brazilian experience with 29 patients (2002\u20132004)","volume":"24","author":"Scheinberg","year":"2006","journal-title":"Clin Exp Rheumatol"},{"issue":"13","key":"10.1016\/j.iac.2015.05.001_bib105","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJM199003293221301","article-title":"Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan","volume":"322","author":"Hertzman","year":"1990","journal-title":"N\u00a0Engl J Med"},{"issue":"46","key":"10.1016\/j.iac.2015.05.001_bib106","first-page":"785","article-title":"Eosinophilia-myalgia syndrome and L-tryptophan-containing products\u2013New Mexico, Minnesota, Oregon, and New York, 1989","volume":"38","author":"Centers for Disease Control (CDC)","year":"1989","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"8690","key":"10.1016\/j.iac.2015.05.001_bib107","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0140-6736(90)90421-Z","article-title":"L-tryptophan and eosinophilia-myalgia syndrome in New Mexico","volume":"335","author":"Eidson","year":"1990","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.iac.2015.05.001_bib108","first-page":"1711","article-title":"Eosinophilia-myalgia syndrome: mortality data from the US national surveillance system","volume":"20","author":"Swygert","year":"1993","journal-title":"J\u00a0Rheumatol"},{"issue":"11","key":"10.1016\/j.iac.2015.05.001_bib109","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1002\/art.30514","article-title":"Post-epidemic eosinophilia-myalgia syndrome associated with L-tryptophan","volume":"63","author":"Allen","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.iac.2015.05.001_bib110","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJM199008093230601","article-title":"An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use","volume":"323","author":"Belongia","year":"1990","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.iac.2015.05.001_bib111","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1001\/jama.1990.03450020065028","article-title":"Eosinophilia-myalgia syndrome associated with exposure to tryptophan from a single manufacturer","volume":"264","author":"Slutsker","year":"1990","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.iac.2015.05.001_bib112","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/BF00230724","article-title":"Contaminants in L-tryptophan associated with eosinophilia myalgia syndrome","volume":"25","author":"Hill","year":"1993","journal-title":"Arch Environ Contam Toxicol"},{"issue":"3","key":"10.1016\/j.iac.2015.05.001_bib113","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1172\/JCI116300","article-title":"Pathological and immunological effects of ingesting L-tryptophan and 1,1'-ethylidenebis (L-tryptophan) in Lewis rats","volume":"91","author":"Love","year":"1993","journal-title":"J\u00a0Clin Invest"},{"issue":"12","key":"10.1016\/j.iac.2015.05.001_bib114","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0025-6196(12)61142-2","article-title":"3-(Phenylamino)alanine, a novel aniline-derived amino acid associated with the eosinophilia-myalgia syndrome: a link to the toxic oil syndrome?","volume":"67","author":"Mayeno","year":"1992","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.iac.2015.05.001_bib115","first-page":"26","article-title":"Pathophysiology of the eosinophilia-myalgia syndrome","volume":"46","author":"Silver","year":"1996","journal-title":"J\u00a0Rheumatol Suppl"},{"issue":"4","key":"10.1016\/j.iac.2015.05.001_bib116","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00005792-199007000-00001","article-title":"L-tryptophan-associated eosinophilic perimyositis, neuritis, and fasciitis. A clinicopathologic and laboratory study of 25 patients","volume":"69","author":"Kaufman","year":"1990","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"10.1016\/j.iac.2015.05.001_bib117","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/archderm.1991.01680070059006","article-title":"Idiopathic and L-tryptophan-associated eosinophilic fasciitis before and after L-tryptophan contamination","volume":"127","author":"Blauvelt","year":"1991","journal-title":"Arch Dermatol"},{"issue":"9","key":"10.1016\/j.iac.2015.05.001_bib118","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0025-6196(12)61575-4","article-title":"Eosinophilic fasciitis associated with use of L-tryptophan: a case-control study and comparison of clinical and histopathologic features","volume":"66","author":"Martin","year":"1991","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.iac.2015.05.001_bib119","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000247297","article-title":"Comparison of the pathology of fascia in eosinophilic myalgia syndrome patients and idiopathic eosinophilic fasciitis","volume":"186","author":"Umbert","year":"1993","journal-title":"Dermatology"},{"issue":"11","key":"10.1016\/j.iac.2015.05.001_bib120","doi-asserted-by":"crossref","first-page":"851","DOI":"10.7326\/0003-4819-122-11-199506010-00008","article-title":"The eosinophilia-myalgia syndrome: status of 205 patients and results of treatment 2 years after onset","volume":"122","author":"Hertzman","year":"1995","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.iac.2015.05.001_bib121","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/art.1780360720","article-title":"The spectrum of eosinophilic myositis. Clinical and immunopathogenic studies of three patients, and review of the literature","volume":"36","author":"Kaufman","year":"1993","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.iac.2015.05.001_bib122","first-page":"831","article-title":"Relapsing eosinophilic myositis\u2013a cause of pseudothrombophlebitis in an alcoholic","volume":"14","author":"Kamm","year":"1987","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.iac.2015.05.001_bib123","first-page":"467","article-title":"Relapsing eosinophilic myositis","volume":"10","author":"Sladek","year":"1983","journal-title":"J\u00a0Rheumatol"},{"issue":"8","key":"10.1016\/j.iac.2015.05.001_bib124","first-page":"581","article-title":"Idiopathic eosinophilic myositis","volume":"88","author":"Hall","year":"1995","journal-title":"QJM"},{"issue":"5","key":"10.1016\/j.iac.2015.05.001_bib125","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/jcp.2008.060616","article-title":"Eosinophilia-associated muscle disorders: an immunohistological study with tissue localisation of major basic protein in distinct clinicopathological forms","volume":"62","author":"Cantarini","year":"2009","journal-title":"J\u00a0Clin Pathol"},{"issue":"1","key":"10.1016\/j.iac.2015.05.001_bib126","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1046\/j.1468-1331.2003.00481.x","article-title":"Eosinophilic major basic protein and interleukin-5 in eosinophilic myositis","volume":"10","author":"Murata","year":"2003","journal-title":"Eur J Neurol"},{"issue":"4\u20135","key":"10.1016\/j.iac.2015.05.001_bib127","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.autrev.2014.01.018","article-title":"Eosinophilic myositis: an updated review","volume":"13","author":"Selva-O'Callaghan","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.iac.2015.05.001_bib128","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/00002281-199811000-00002","article-title":"Eosinophilic myopathic syndromes","volume":"10","author":"Pickering","year":"1998","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"10.1016\/j.iac.2015.05.001_bib129","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/PL00011210","article-title":"Focal eosinophilic myositis","volume":"20","author":"Kobayashi","year":"2001","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.iac.2015.05.001_bib130","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/mus.880130505","article-title":"Fasciitis, perimyositis, myositis, polymyositis, and eosinophilia","volume":"13","author":"Serratrice","year":"1990","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.iac.2015.05.001_bib131","first-page":"273","article-title":"Eosinophilic myositis resulting from sarcocystosis","volume":"98","author":"Van den Enden","year":"1995","journal-title":"J\u00a0Trop Med Hyg"},{"issue":"4","key":"10.1016\/j.iac.2015.05.001_bib132","doi-asserted-by":"crossref","first-page":"548","DOI":"10.4269\/ajtmh.1999.61.548","article-title":"An outbreak of acute eosinophilic myositis attributed to human sarcocystis parasitism","volume":"61","author":"Arness","year":"1999","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"10.1016\/j.iac.2015.05.001_bib133","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/ana.410320409","article-title":"Skeletal muscle toxoplasmosis in patients with acquired immunodeficiency syndrome: a clinical and pathological study","volume":"32","author":"Gherardi","year":"1992","journal-title":"Ann Neurol"},{"issue":"10","key":"10.1016\/j.iac.2015.05.001_bib134","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/cid\/ciu622","article-title":"Acute muscular sarcocystosis: an international investigation among ill travelers returning from Tioman Island, Malaysia, 2011-2012","volume":"59","author":"Esposito","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.iac.2015.05.001_bib135","doi-asserted-by":"crossref","first-page":"e2876","DOI":"10.1371\/journal.pntd.0002876","article-title":"Sarcocystis nesbitti causes acute, relapsing febrile myositis with a high attack rate: description of a large outbreak of muscular sarcocystosis in Pangkor Island, Malaysia, 2012","volume":"8","author":"Italiano","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"10.1016\/j.iac.2015.05.001_bib136","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/jcp.2003.013409","article-title":"Churg-Strauss vasculitis diagnosed on muscle biopsy","volume":"57","author":"Suresh","year":"2004","journal-title":"J\u00a0Clin Pathol"},{"issue":"2","key":"10.1016\/j.iac.2015.05.001_bib137","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/088307389701200214","article-title":"Becker muscular dystrophy presenting as eosinophilic inflammatory myopathy in an infant","volume":"12","author":"Weinstock","year":"1997","journal-title":"J\u00a0Child Neurol"},{"issue":"6","key":"10.1016\/j.iac.2015.05.001_bib138","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/ana.20833","article-title":"CAPN3 mutations in patients with idiopathic eosinophilic myositis","volume":"59","author":"Krahn","year":"2006","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.iac.2015.05.001_bib139","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/ana.20900","article-title":"Calpainopathy and eosinophilic myositis","volume":"59","author":"Brown","year":"2006","journal-title":"Ann Neurol"},{"issue":"9","key":"10.1016\/j.iac.2015.05.001_bib140","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1212\/01.wnl.0000287138.89373.6b","article-title":"Adults with eosinophilic myositis and calpain-3 mutations","volume":"70","author":"Amato","year":"2008","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.iac.2015.05.001_bib141","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.nmd.2008.11.010","article-title":"Eosinophilic myositis as presenting symptom in gamma-sarcoglycanopathy","volume":"19","author":"Baumeister","year":"2009","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"10.1016\/j.iac.2015.05.001_bib142","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.nmd.2014.09.009","article-title":"Eosinophilic myositis as first manifestation in a patient with type 2 myotonic dystrophy CCTG expansion mutation and rheumatoid arthritis","volume":"25","author":"Meyer","year":"2015","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"10.1016\/j.iac.2015.05.001_bib143","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.nmd.2009.01.010","article-title":"Eosinophilic myositis in calpainopathy: could immunosuppression of the eosinophilic myositis alter the early natural course of the dystrophic disease?","volume":"19","author":"Oflazer","year":"2009","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"10.1016\/j.iac.2015.05.001_bib144","first-page":"148","article-title":"Eosinophils in hereditary and inflammatory myopathies","volume":"32","author":"Schroder","year":"2013","journal-title":"Acta Myol"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856115000326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856115000326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T17:19:26Z","timestamp":1652462366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856115000326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":144,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0889856115000326"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2015.05.001","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eosinophilia in Rheumatologic\/Vascular Disorders","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2015.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}